Celecoxib for Thyroid Eye Disease

NCT02845336 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Poor enrollment

Conditions

Thyroid Eye Disease

Interventions

DRUG: Celecoxib
DRUG: artificial tears

Sponsor

Johns Hopkins University